Clinical Trials in Kalmar, Sweden
8 recruiting
Showing 1–10 of 10 trials
Recruiting
Not Applicable
Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
Cardiovascular Diseases
Linkoeping University750 enrolled12 locationsNCT05641662
Recruiting
Phase 3
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
High-risk Melanoma
Uppsala University1,792 enrolled26 locationsNCT06488482
Recruiting
Not Applicable
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Social Anxiety DisorderGeneralized Anxiety DisorderSpecific Phobia+4 more
Lund University48 enrolled1 locationNCT06661460
Recruiting
Phase 3
Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
Ureter CancerRenal CancerOther Specified Disorders of Kidney and Ureter+5 more
Hans Bahlmann220 enrolled3 locationsNCT06349668
Recruiting
Not Applicable
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
Prostate Cancer
Lund University Hospital374 enrolled3 locationsNCT04858880
Recruiting
Phase 3
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Karolinska Institutet750 enrolled32 locationsNCT03903835
Recruiting
Not Applicable
A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
Malignant Melanoma
Uppsala University1,300 enrolled20 locationsNCT03116412
Recruiting
Not Applicable
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Breast Cancer
Region Skane1,350 enrolled26 locationsNCT05634889
Recruiting
Phase 3
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
DeathAtrial FibrillationChronic Kidney Diseases+6 more
Region Stockholm1,400 enrolled34 locationsNCT05679024
Recruiting
Phase 3
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Diffuse Large B Cell LymphomaDLBCL
Nordic Lymphoma Group300 enrolled69 locationsNCT04332822